Biomarkers for irritable bowel syndrome: Successful identification of an organic cause of irritable bowel syndromes
IBS is considered a mild form of inflammatory bowel disease. Second, patients with quiescence ulcerative colitis report IBS-like symptoms. The supernatants from these patients also activated neurons.
In summary, we can conclude that protease profiling is a promising strategy for the development of irritable bowel syndrome biomarkers," said Schemann -- "they provide additional evidence for a defined organic causes for irritable bowel syndrome."